Literature DB >> 3297309

c-myc amplification and expression in newly established human osteosarcoma cell lines.

E Bogenmann, H Moghadam, Y A DeClerck, A Mock.   

Abstract

Three cell lines were isolated from a patient with osteosarcoma of the femur. These lines were obtained from the primary neoplasm before (HTLA145) and after (HTLA161) chemotherapy and from a metastasis of the lung (HTLA195) in the same patient. The three cell lines exhibited a similar morphology in culture and formed tumors in nude mice which demonstrated a histopathology similar to that which had been observed in the patient. High expression of the genes coding for the alpha-1 and alpha-2 chain of collagen Type I was found in vitro and in s.c. tumors growing in nude mice. The c-myc protooncogene was amplified in all three cell lines and extensive expression of c-myc was found in vitro and in vivo. No heterogeneity in regard to c-myc expression in vivo was detected by in situ localization in tumors growing in nude mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297309

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.

Authors:  C M Cannon; J Pozniak; M C Scott; D Ito; B H Gorden; A J Graef; J F Modiano
Journal:  Vet Comp Oncol       Date:  2013-02-15       Impact factor: 2.613

2.  Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.

Authors:  Dhong Hyun Lee; Nils H Thoennissen; Catherine Goff; Gabriela B Iwanski; Charles Forscher; Ngan B Doan; Jonathan W Said; H Phillip Koeffler
Journal:  Cancer Lett       Date:  2011-03-26       Impact factor: 8.679

3.  Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.

Authors:  Venugopal Thayanithy; Aaron L Sarver; Reena V Kartha; Lihua Li; Andrea Y Angstadt; Matthew Breen; Clifford J Steer; Jaime F Modiano; Subbaya Subramanian
Journal:  Bone       Date:  2011-10-18       Impact factor: 4.398

Review 4.  MicroRNAs in the pathobiology of sarcomas.

Authors:  Anne E Sarver; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

5.  Nerve growth factor (NGF) induces neuronal differentiation in neuroblastoma cells transfected with the NGF receptor cDNA.

Authors:  H Matsushima; E Bogenmann
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  Two distinct cell lines derived from a human osteosarcoma.

Authors:  A Kawai; T Ozaki; S Ikeda; T Oda; M Miyazaki; J Sato; K Taketa; H Inoue
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma.

Authors:  Dhong Hyun Lee; Jun Qi; James E Bradner; Jonathan W Said; Ngan B Doan; Charles Forscher; Henry Yang; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2014-10-30       Impact factor: 7.396

8.  Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.

Authors:  T Ueda; J H Healey; A G Huvos; M Ladanyi
Journal:  Sarcoma       Date:  1997

9.  Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma.

Authors:  Lauren J Mills; Milcah C Scott; Pankti Shah; Anne R Cunanan; Archana Deshpande; Benjamin Auch; Bridget Curtin; Kenneth B Beckman; Logan G Spector; Aaron L Sarver; Subbaya Subramanian; Todd A Richmond; Jaime F Modiano
Journal:  Bone       Date:  2020-10-27       Impact factor: 4.398

10.  Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.

Authors:  Venugopal Thayanithy; ChangWon Park; Aaron L Sarver; Reena V Kartha; Derek M Korpela; Ashley J Graef; Clifford J Steer; Jaime F Modiano; Subbaya Subramanian
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.